Skip to Main Content

Paper Details

Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma.
Mol Cancer Ther
7
2022
Cas9, ERK, FTI, Farnesyltransferase, HNSCC, HRAS, HRAS Mutant, HRAS mutant, HRAS mutations, HRAS-mutant HNSCC, HRAS-mutant HNSCC cell lines, HRAS-mutant HNSCC lines, HRAS-mutant cancers, Human, Human papilloma virus, PI3K, cancer, epithelial, farnesyltransferase, head and neck squamous cell carcinoma, mTORC1, patients, tipifarnib, tumors
Author NameAffiliation
Mariaelena PierobonCenter for Applied Proteomics and Molecular Medicine, Institute for Advanced Biomedical Research, George Mason University
Kris C WoodDuke University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, Institute for Advanced Biomedical Research, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, Institute for Advanced Biomedical Research, George Mason University
  • 1 - 4

Datasets

Release 1.2